Capital Square’s Organogenesis Holdings ORGO Stock Holding History

Capital Square’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.8K	Hold	18,813	–	–	0.01%	245
2026 Q2	$45.2K	Sell	18,813 -300	-2%	-$733	0.02%	234
2026 Q1	$44.9K	Buy	19,113 +8,305	+77%	+$28.8K	0.02%	221
2025 Q4	$56K	Sell	10,808 -6,202	-36%	-$30K	0.03%	210
2025 Q3	$71.8K	Sell	17,010 -5,490	-24%	-$25.5K	0.04%	199
2025 Q2	$96.8K	Sell	22,500 -600	-3%	-$2.24K	0.05%	186
2025 Q1	$100K	Buy	23,100 +500	+2%	+$2.02K	0.06%	175
2024 Q4	$80.5K	Buy	22,600 +2,000	+10%	+$6.71K	0.05%	174
2024 Q3	$58.9K	Buy	20,600 +300	+1%	+$841	0.04%	155
2024 Q2	$61.3K	Buy	20,300 +50	+0.2%	+$134	0.04%	143
2024 Q1	$57.5K	Sell	20,250 -200	-1%	-$680	0.04%	141
2023 Q4	$83.6K	Buy	20,450 +3,930	+24%	+$11K	0.09%	95
2023 Q3	$38.8K	Buy	+16,520	New	+$52.5K	0.05%	87

Other funds holding ORGO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Capital Square's ORGO Position: Q3 2026 in Review

Capital Square held its Organogenesis Holdings (ORGO) position steady in Q3 2026 at 18,813 shares worth $25.8K. The position accounts for 0.01% of the portfolio, ranked #245.

Capital Square first reported a position in ORGO in Q3 2023 and has held it in 13 quarters since. The position peaked at $100K in Q1 2025. 12 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

Capital Square held 18,813 shares of Organogenesis Holdings worth $25.8K as of Q3 2026.
Capital Square left its Organogenesis Holdings share count unchanged in Q3 2026.
Organogenesis Holdings made up 0.01% of Capital Square's portfolio in Q3 2026, its #245 holding.
Capital Square first reported a position in Organogenesis Holdings in Q3 2023 and has held it in 13 quarters since.
Capital Square's Organogenesis Holdings position peaked at $100K in Q1 2025.
12 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Capital Square's 13F filing for Q3 2026, filed 19 Oct 2026.